Sea Crest Wealth Management, LLC Magenta Therapeutics, Inc. Transaction History

Sea Crest Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$9.76 - $14.15 $304,394 - $441,310	-31,188 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.66 - $13.38 $238,900 - $417,295	31,188 New	31,188 $369,000
Q2 2019 Jul 19, 2019	SELL	$13.4 - $17.67 $5,360 - $7,068	-400 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$5.57 - $11.65 $2,228 - $4,660	-400 Reduced 50.0%	400 $2,000
Q3 2018 Nov 14, 2018	SELL	$11.32 - $15.7 $2,264 - $3,140	-200 Reduced 20.0%	800 $10,000
Q2 2018 Aug 03, 2018	BUY	$13.5 - $14.52 $13,500 - $14,520	1,000 New	1,000 $14,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.